Kei Fukuhara
4PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|Jun 21, 2025
Evaluation of Characteristics and Ethnic Sensitivity for FDA-Approved Drugs with Racial and Ethnic Differences in Pharmacokinetics, Safety, and Efficacy.Kei Fukuhara, Yusuke Tanetsugu, Shinsuke Wada
|May 22, 2025
Comparison of Population Pharmacokinetics-Related Information in Drug Labeling Between Japan, the United States, and the European Union.Kei Fukuhara, Mamoru Narukawa
|May 21, 2025
New Horizon in Clinical Development Strategy in Japan Based on New Guideline on Japanese Phase 1 Studies Prior to Multi-Regional Clinical Trials.Kei Fukuhara, Takako Shimizu, Junichi Yamamoto
|Mar 11, 2025
Japanese Phase 1 Study for Global Development of Anti-TL1A Antibody PF-06480605: A Randomized, Placebo-Controlled, Single-Ascending Dose Study.Kei Fukuhara, Srividya Neelakantan, Kenichi Furihata
Pageof 1
